Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

KannaLife Sciences Inc.

www.kannalife.com

Latest From KannaLife Sciences Inc.

Start-Up Quarterly Statistics, Q3 2012

In the third quarter of 2012, start-up companies raised a total of $682 million across all industries, roughly 19% more than in the previous quarter. Of that money, 65% went to biopharmas. Several large molecule-focused companies inked deals during Q3. Four start-ups were acquired – three biopharmas and one medical device company.

BioPharmaceutical Medical Device

Recent Tech Transfer Deals, September 2012

START-UP’s monthly update on technology transfer deals—licensing agreements between companies and universities or other research institutions—in in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical equipment & supplies.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • KannaLife Sciences Inc.
  • Senior Management
  • Dean Petkanas, Chmn. & CEO
    Mark Corrao, CFO
    Ramesh C Pandey, PhD, CSO
  • Contact Info
  • KannaLife Sciences Inc.
    Phone: (516) 669-3219
    3870 Review Ave. #2
    Long Island City, NY 11101
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register